123 related articles for article (PubMed ID: 7509999)
21. Phosphoramidon-sensitive endothelin converting enzyme in cultured vascular smooth muscle cells converts big endothelin-3 to endothelin-3.
Tsukahara Y; Matsumura Y; Kuninobu K; Kojima T; Takaoka M; Morimoto S
Life Sci; 1993; 53(6):465-71. PubMed ID: 8341132
[TBL] [Abstract][Full Text] [Related]
22. Importance of the C-terminal region of big endothelin-1 for specific conversion by phosphoramidon-sensitive endothelin converting enzyme.
Okada K; Takada J; Arai Y; Matsuyama K; Yano M
Biochem Biophys Res Commun; 1991 Oct; 180(2):1019-23. PubMed ID: 1953706
[TBL] [Abstract][Full Text] [Related]
23. Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzyme.
Ikegawa R; Matsumura Y; Tsukahara Y; Takaoka M; Morimoto S
Biochem Biophys Res Commun; 1990 Sep; 171(2):669-75. PubMed ID: 2206130
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-converting enzyme in the human vasculature: evidence for differential conversion of big endothelin-3 by endothelial and smooth-muscle cells.
Davenport AP; Kuc RE; Mockridge JW
J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S1-3. PubMed ID: 9595383
[TBL] [Abstract][Full Text] [Related]
25. A comparison of endothelin-converting enzyme activity from primary porcine aortic endothelial cells with activities in cultured human cell lines.
Knap AK; Wigg AM
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S90-3. PubMed ID: 8121180
[TBL] [Abstract][Full Text] [Related]
26. Effect of phosphoramidon on big endothelin-2 conversion into endothelin-2 in human renal adenocarcinoma (ACHN) cells. Analysis of endothelin-2 biosynthetic pathway.
Yorimitsu K; Shinmi O; Nishiyama M; Moroi K; Sugita Y; Saito T; Inagaki Y; Masaki T; Kimura S
FEBS Lett; 1992 Dec; 314(3):395-8. PubMed ID: 1468574
[TBL] [Abstract][Full Text] [Related]
27. The expression of endothelin-1 and endothelin-converting enzyme-1 (ECE-1) are independently regulated in bovine aortic endothelial cells.
Corder R; Barker S
J Cardiovasc Pharmacol; 1999 Apr; 33(4):671-7. PubMed ID: 10218741
[TBL] [Abstract][Full Text] [Related]
28. A rapid and selective endothelin-converting enzyme assay: characterization of a phosphoramidon-sensitive enzyme from guinea pig lung membrane.
Fawzi AB; Cleven RM; Wright DL
Anal Biochem; 1994 Nov; 222(2):342-50. PubMed ID: 7864357
[TBL] [Abstract][Full Text] [Related]
29. Endothelin-1 pathway in human alveolar epithelial cell line A549 and human umbilical vein endothelial cells.
Deprez-Roy I; Coge F; Bertry L; Galizzi JP; Feletou M; Vanhoutte PM; Canet E
Acta Pharmacol Sin; 2000 Jun; 21(6):499-506. PubMed ID: 11360683
[TBL] [Abstract][Full Text] [Related]
30. Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA.
Warner TD; Budzik GP; Matsumoto T; Mitchell JA; Förstermann U; Murad F
Br J Pharmacol; 1992 Aug; 106(4):948-52. PubMed ID: 1393292
[TBL] [Abstract][Full Text] [Related]
31. Guinea pig Clara cells secrete endothelin 1 through a phosphoramidon-sensitive pathway.
Laporte J; D'Orléans-Juste P; Sirois P
Am J Respir Cell Mol Biol; 1996 Apr; 14(4):356-62. PubMed ID: 8600940
[TBL] [Abstract][Full Text] [Related]
32. Identification and characterization of endothelin converting activity from EAHY 926 cells: evidence for the physiologically relevant human enzyme.
Waxman L; Doshi KP; Gaul SL; Wang S; Bednar RA; Stern AM
Arch Biochem Biophys; 1994 Jan; 308(1):240-53. PubMed ID: 8311460
[TBL] [Abstract][Full Text] [Related]
33. Endothelin-converting enzyme activity in human cerebral circulation.
Vatter H; Mursch K; Zimmermann M; Zilliken P; Kolenda H; Seifert V; Schilling L
Neurosurgery; 2002 Aug; 51(2):445-51; discussion 451-2. PubMed ID: 12182783
[TBL] [Abstract][Full Text] [Related]
34. A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells.
Ahn K; Pan S; Beningo K; Hupe D
Life Sci; 1995; 56(26):2331-41. PubMed ID: 7791520
[TBL] [Abstract][Full Text] [Related]
35. cDNA cloning and expression of bovine endothelin converting enzyme.
Ikura T; Sawamura T; Shiraki T; Hosokawa H; Kido T; Hoshikawa H; Shimada K; Tanzawa K; Kobayashi S; Miwa S
Biochem Biophys Res Commun; 1994 Sep; 203(3):1417-22. PubMed ID: 7945289
[TBL] [Abstract][Full Text] [Related]
36. Human breast cancer cells contain a phosphoramidon-sensitive metalloproteinase which can process exogenous big endothelin-1 to endothelin-1: a proposed mitogen for human breast fibroblasts.
Patel KV; Schrey MP
Br J Cancer; 1995 Mar; 71(3):442-7. PubMed ID: 7880721
[TBL] [Abstract][Full Text] [Related]
37. Big endothelin-1 structure important for specific processing by endothelin-converting enzyme of bovine endothelial cells.
Okada K; Arai Y; Hata M; Matsuyama K; Yano M
Eur J Biochem; 1993 Dec; 218(2):493-8. PubMed ID: 8269939
[TBL] [Abstract][Full Text] [Related]
38. Effect of endothelin-converting enzyme inhibitors on big endothelin-1 induced contraction in isolated rat basilar artery.
Zimmermann M; Jung CS; Vatter H; Raabe A; Seifert V
Acta Neurochir (Wien); 2002 Nov; 144(11):1213-9. PubMed ID: 12434178
[TBL] [Abstract][Full Text] [Related]
39. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1.
Xu D; Emoto N; Giaid A; Slaughter C; Kaw S; deWit D; Yanagisawa M
Cell; 1994 Aug; 78(3):473-85. PubMed ID: 8062389
[TBL] [Abstract][Full Text] [Related]
40. Endothelin-converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon.
Keller PM; Lee CP; Fenwick AE; Atkinson ST; Elliott JD; DeWolf WE
Biochem Biophys Res Commun; 1996 Jun; 223(2):372-8. PubMed ID: 8670289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
